sulfamonomethoxine has been researched along with Cancer of Liver in 1 studies
Sulfamonomethoxine: Long acting sulfonamide antibacterial agent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Niu, Y | 1 |
Lin, Z | 1 |
Wan, A | 1 |
Sun, L | 1 |
Yan, S | 1 |
Liang, H | 1 |
Zhan, S | 1 |
Chen, D | 1 |
Bu, X | 1 |
Liu, P | 1 |
Chen, C | 1 |
He, W | 1 |
Lu, X | 1 |
Wan, G | 1 |
1 other study available for sulfamonomethoxine and Cancer of Liver
Article | Year |
---|---|
Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; | 2021 |